Alpha Tau Medical (DRTS) Accumulated Depreciation (2020 - 2025)
Alpha Tau Medical (DRTS) posted Accumulated Depreciation of $5.3 million for Q4 2025, up 30.1% sequentially from $4.1 million in Q4 2024, and up 30.1% YoY from $4.1 million in Q4 2024.
Alpha Tau Medical (DRTS) Accumulated Depreciation (2020 - 2025) Analysis & Trends
Alpha Tau Medical has reported Accumulated Depreciation for 5 years, with the latest figure at $5.3 million in Q4 2025.
- Quarterly Accumulated Depreciation rose 30.1% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (up 30.1% YoY) and the FY2025 annual result came in at $5.3 million, up 30.1% from the prior year.
- Accumulated Depreciation rose to $5.3 million in Q4 2025 per DRTS's latest filing, from $4.1 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $5.3 million in Q4 2025 and troughed at $912000.0 in Q4 2021.
- A 4-year average of $3.3 million and a median of $3.5 million in 2023 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2021 and 2025: Accumulated Depreciation surged 436.47% in 2021, then soared 30.1% in 2025.
- Over 4 years, Accumulated Depreciation stood at $912000.0 in 2021, then soared by 225.11% to $3.0 million in 2023, then jumped by 36.69% to $4.1 million in 2024, then jumped by 30.1% to $5.3 million in 2025.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $5.3 million, $4.1 million, and $3.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.27 Mn |
| Dec 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | 2.97 Mn |
| Dec 31, 2021 | 912,000.00 |
| Dec 31, 2020 | 170,000.00 |